Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

28-May-2013 [ | E-mail | ] Contact: Kristal GriffithKristal.Griffith@iaslc.org 720-325-2952International Association for the Study of Lung Cancer Find higher levels of programmed death ligand-1 in rare disease DENVER Sarcomatoid carcinomas of the lung include rare subtypes of poorly… http://healthmedicinet.com/i/researchers-provide-rationale-for-use-of-targeted-immunotherapy-in-sarcomatoid-lung-carcinomas/